Evidence map›Paper›PMID 37242777›Full record

ArticlePharmaceutics2023

Antiparasitic Activity of

Raiza Brandão Peres, Marcos Meuser Batista, Ana Luíza Rangel Bérenger, Flávia da Cunha Camillo, Maria Raquel Figueiredo, Maria de Nazaré Correia Soeiro

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Phenotypic Analysis of the Anti-Molecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raiza Brandão PeresLaboratório de Biologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 210360-040, Brazil.
Marcos Meuser BatistaLaboratório de Biologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 210360-040, Brazil.
Ana Luíza Rangel BérengerLaboratório de Tecnologia para Biodiversidade em Saúde-TecBio/LDFito, Instituto de Tecnologia em Fármacos (Farmanguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21041-250, Brazil.
Flávia da Cunha CamilloLaboratório de Tecnologia para Biodiversidade em Saúde-TecBio/LDFito, Instituto de Tecnologia em Fármacos (Farmanguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21041-250, Brazil.
Maria Raquel FigueiredoLaboratório de Tecnologia para Biodiversidade em Saúde-TecBio/LDFito, Instituto de Tecnologia em Fármacos (Farmanguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21041-250, Brazil.
Maria de Nazaré Correia SoeiroLaboratório de Biologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 210360-040, Brazil.
Fundação Oswaldo Cruz · BR

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E26200-825/2021National Council for Scientific and Technological Development 302160/2019-1National Council for Scientific and Technological Development 400043/2017-3National Council for Scientific and Technological Development 404166/2021-0Oswaldo Cruz Foundation Paef
6 · The paper itself

Abstract

Chagas disease (CD) caused by the protozoan

Indexed as

Chagas diseasedrug combinationin silico ADMETnaphthoquinonenatural productsPlumbaginPlumbago auriculata

Identifiers

PMID37242777
PMCPMC10221501
OpenAlexW4377097943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.